Live News Categoriesmarket

CNTB.O (CNTB.O) News

Track canonical SquawkNews coverage tagged to CNTB.O, CNTB.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CNTB.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 11:06 AM UTC Open live news feed

M Connect Biopharma says rademikibart cuts COPD treatment failure rate 81% in Phase 2 Connect Biopharma reported preliminary topline results from a global Phase 2 trial of rademikibart in acute COPD flare-ups, cutting post-flare treatment failures versus placebo by 81% through Week 4 and planning to seek EARNINGS | Sep 30, 2026, 11:06 AM UTC